Uipath Inc SEC Filings

UiPath insider sale reported by CEO and Chairman Daniel Dines. The filing shows that on 10/09/2025 Mr. Dines (reporting person) caused the sale of multiple blocks of Class A Common Stock, including a discrete disposal of 29,918,585 shares and a separate sale of 122,734 shares at an average price range of $16.21 to $16.98 (reported price point $16.5743). The Form 4 states the trades were executed under a Rule 10b5-1 selling plan. After the reported transactions, Mr. Dines retains indirect beneficial ownership of 613,670 shares and a separate indirect holding of 240,000 shares held by his spouse via related entities, with voting and investment power retained through Ice Vulcan entities.

UiPath, Inc. reported a proposed insider sale under Rule 144 for 240,874 common shares with an aggregate market value of $3,752,816.92. The filing shows the shares are to be sold on or about 10/09/2025 on the NYSE through Morgan Stanley Smith Barney LLC. The position being sold was acquired in two tranches: 148,009 shares from an exercise of stock options on 10/09/2025 (paid in cash) and 92,865 shares from restricted stock units on 01/01/2024.

The filer certifies there were no sales by the same person in the past three months and affirms no undisclosed material adverse information is known. The form is marked as a LIVE filing and includes broker and share-outstanding details: 453,568,899 shares outstanding were reported in the table.

Daniel Dines, CEO and Chairman of UiPath, Inc. (PATH), reported a sale of 122,734 shares of Class A common stock executed on 10/08/2025 under a qualified Rule 10b5-1 selling plan. The filing lists a reported price figure of $14.8901 and a disclosed transaction price range from $14.7700 to $15.0400. After the reported transactions the document shows 736,404 shares beneficially owned in an indirect form through Ice Vulcan Holding Limited, an entity ultimately owned by Mr. Dines; the filing states he retains sole voting and investment power over those shares. The sale was executed by an attorney-in-fact on behalf of the reporting person.

UiPath insider sale under written plan: The Form 4 shows that Daniel Dines, CEO and Chairman of UiPath, sold 122,733 shares of Class A common stock on 10/07/2025 under a Rule 10b5-1 qualified selling plan. The reported sale price on the form is $14.9899, with the disclosed transaction price range of $14.70 to $15.14. After the reported transaction, the form lists 859,138 shares beneficially owned indirectly and describes ownership through Ice Vulcan entities, with Mr. Dines retaining sole voting and investment power. The filing was signed by an attorney-in-fact on 10/07/2025.

UiPath, Inc. (PATH) reporting person Brad Brubaker, GC & Chief Legal Officer, disclosed a sale of 66,665 shares of Class A common stock on 10/06/2025 under a pre-established Rule 10b5-1 selling plan. The reported sale prices ranged from $15.0000 to $15.0050, and after the transaction Mr. Brubaker beneficially owned 690,519 shares directly.

The filing confirms the sale was executed pursuant to a qualified 10b5-1 plan and the filer offered to provide transaction-level price details to the Commission staff or security holders upon request. No derivative transactions or other changes in beneficial ownership were reported on this form.

UiPath (PATH) CEO and Chairman Daniel Dines reported an open-market sale of 122,733 shares of Class A common stock on 10/06/2025, coded “S,” executed under a Rule 10b5-1 trading plan. The weighted average sales price was $14.2442, with trades between $13.9200 and $14.5000. Following the sale, he beneficially owned 29,918,585 shares directly, 981,871 shares indirectly (per Ice Vulcan structure), and 240,000 shares indirectly by spouse.

UiPath, Inc. insider filing notifies a proposed sale of 66,665 common shares through Morgan Stanley Smith Barney on the NYSE with an aggregate market value listed as $859,978.50. The shares were acquired as Restricted Stock Units on 07/01/2023, with the filing indicating an approximate sale date of 10/06/2025. The filer disclosed prior automated 10b5-1 sales of 16,083 shares on 09/30/2025 generating gross proceeds of $241,262.69. The notice includes the standard signer representation that the seller has no undisclosed material adverse information.

UiPath, Inc. (PATH) filed a Form 144 reporting a proposed sale of 1,000,000 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $12,900,000. The filing states these are founders' shares acquired on 04/21/2021 and indicates the sale is expected on or about 10/06/2025 on the NYSE. The filer represents no undisclosed material information and notes prior Rule 10b5-1 program sales totaling multiple transactions in the past three months, including repeated daily lots of 122,733 shares and several blocks of 45,000 shares, producing gross proceeds listed per trade. The notice identifies total shares outstanding as 453,568,899, which frames the proposed sale as a small fraction of the outstanding base.

UiPath director, CEO and 10% owner Daniel Dines reported multiple dispositions on 10/03/2025. The filing shows a sale of 122,733 shares of Class A common stock at prices ranging from $12.75 to $13.13, executed under a qualified Rule 10b5-1 selling plan. The report also records a separate disposition of 29,918,585 Class A shares and indicates beneficial ownership of 1,104,604 shares indirectly through Ice Vulcan Holding Limited, plus 240,000 shares held indirectly by his spouse. The form is signed by an attorney-in-fact on behalf of Mr. Dines.